SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.
Ontology highlight
SUBMITTER: Zhu Y
PROVIDER: S-EPMC8330190 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA